Skip to main content

Sorrento Therapeutics, Inc. (NASDAQ: SRNE) Investor Securities Class Action Lawsuit 07/27/2020

  • If you purchased shares of Sorrento Therapeutics, Inc. (NASDAQ: SRNE), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

November 18, 2021 - The court granted the defendants' motion to dismiss. The plaintiffs were given leave to amend the complaint. May 20, 2021 - A motion to dismiss the consolidated complaint was filed. April 5, 2021 - A consolidated complaint was filed. July 27, 2020 - An investor in shares of Sorrento Therapeutics, Inc. (NASDAQ: SRNE) filed a lawsuit in the U.S. District Court for th...



You must register (for free) or login to view the entire case.